Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic BoundariesMichael E. Talkowski, James F. Gusella, Ian Blumenthal et al.|Cell|2012Cited by 598
Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Kapil N. Bhalla|Oncotarget|2014Cited by 159